Plaque Evaluation by Ultrasound and Transcriptomics Reveals BCLAF1 as a Regulator of Smooth Muscle Cell Lipid Transdifferentiation in Atherosclerosis

Background: Understanding the processes behind carotid plaque instability is necessary to develop methods for identification of patients and lesions with stroke risk. Here, we investigated molecular signatures in human plaques stratified by echogenicity as assessed by duplex ultrasound. Methods: Lesion echogenicity was correlated to microarray gene expression profiles from carotid endarterectomies (n=96). The findings were extended into studies of human and mouse atherosclerotic lesions in situ, followed by functional investigations in vitro in human carotid smooth muscle cells (SMCs). Results: Pathway analyses highlighted muscle differentiation, iron homeostasis, calcification, matrix organization, cell survival balance, and BCLAF1 (BCL2 [B-cell lymphoma 2]-associated transcription factor 1) as the most significant signatures. BCLAF1 was downregulated in echolucent plaques, positively correlated to proliferation and negatively to apoptosis. By immunohistochemistry, BCLAF1 was found in normal medial SMCs. It was repressed early during atherogenesis but reappeared in CD68+ cells in advanced plaques and interacted with BCL2 by proximity ligation assay. In cultured SMCs, BCLAF1 was induced by differentiation factors and mitogens and suppressed by macrophage-conditioned medium. BCLAF1 silencing led to downregulation of BCL2 and SMC markers, reduced proliferation, and increased apoptosis. Transdifferentiation of SMCs by oxLDL (oxidized low-denisty lipoprotein) was accompanied by upregulation of BCLAF1, CD36, and CD68, while oxLDL exposure with BCLAF1 silencing preserved MYH (myosin heavy chain) 11 expression and prevented transdifferentiation. BCLAF1 was associated with expression of cell differentiation, contractility, viability, and inflammatory genes, as well as the scavenger receptors CD36 and CD68. BCLAF1 expression in CD68+/BCL2+ cells of SMC origin was verified in plaques from MYH11 lineage-tracing atherosclerotic mice. Moreover, BCLAF1 downregulation associated with vulnerability parameters and cardiovascular risk in patients with carotid atherosclerosis. Conclusions: Plaque echogenicity correlated with enrichment of distinct molecular pathways and identified BCLAF1, previously not described in atherosclerosis, as the most significant gene. Functionally, BCLAF1 seems necessary for survival and transdifferentiation of SMCs into a macrophage-like phenotype. The role of BCLAF1 in plaque vulnerability should be further evaluated.

[1]  Yizuo Song,et al.  Effects of Galectin-1 on Biological Behavior in Cervical Cancer , 2020, Journal of Cancer.

[2]  Clint L. Miller,et al.  Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis , 2019, Nature Medicine.

[3]  P. Eriksson,et al.  High-Resolution Regulatory Maps Connect Vascular Risk Variants to Disease-Related Pathways , 2019, Circulation. Genomic and precision medicine.

[4]  S. Schwartz.  Faculty Opinions recommendation of Corrigendum: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[5]  C. Grönlund,et al.  Risk Marker Variability in Subclinical Carotid Plaques Based on Ultrasound is Influenced by Cardiac Phase, Echogenicity and Size. , 2018, Ultrasound in medicine & biology.

[6]  Christopher S. Hughes,et al.  Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics. , 2018, Journal of proteome research.

[7]  R. Virmani,et al.  Intravascular ultrasound and near-infrared spectroscopic features of coronary lesions with intraplaque haemorrhage , 2017, European heart journal cardiovascular Imaging.

[8]  Vijay Nambi,et al.  Novel Ultrasound Methods to Investigate Carotid Artery Plaque Vulnerability , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  Vagheesh M. Narasimhan,et al.  Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models , 2016, Circulation research.

[10]  Valentina Paloschi,et al.  Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[11]  S. Daskalopoulou,et al.  Plaque echodensity and textural features are associated with histologic carotid plaque instability. , 2016, Journal of vascular surgery.

[12]  Jens-Peter Volkmer,et al.  CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis , 2016, Nature.

[13]  Yu Fan,et al.  Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy , 2016, Tumor Biology.

[14]  A. Gabrielsen,et al.  Gene expression signatures, pathways and networks in carotid atherosclerosis , 2016, Journal of internal medicine.

[15]  J. Tang,et al.  Bclaf1 is an important NF-κB signaling transducer and C/EBPβ regulator in DNA damage-induced senescence , 2016, Cell Death and Differentiation.

[16]  G. Pasterkamp,et al.  Detecting the vulnerable plaque in patients , 2015, Journal of internal medicine.

[17]  R. Marshall,et al.  Moving Beyond Luminal Stenosis: Imaging Strategies for Stroke Prevention in Asymptomatic Carotid Stenosis , 2015, Cerebrovascular Diseases.

[18]  K. Moore,et al.  Cholesterol Loading Reprograms the MicroRNA-143/145–Myocardin Axis to Convert Aortic Smooth Muscle Cells to a Dysfunctional Macrophage-Like Phenotype , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Alexander S. Banks,et al.  Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming , 2014, Genes & development.

[20]  R. Feil,et al.  Transdifferentiation of Vascular Smooth Muscle Cells to Macrophage-Like Cells During Atherogenesis , 2014, Circulation research.

[21]  E. Díez-Tejedor,et al.  A prediction model for unstable carotid atheromatous plaque in acute ischemic stroke patients: proposal and internal validation. , 2014, Ultrasound in medicine & biology.

[22]  Jing Fang,et al.  BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells , 2014, Nature Communications.

[23]  S. Allahverdian,et al.  Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis , 2014, Circulation.

[24]  Clint L. Miller,et al.  Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. , 2014, The Journal of clinical investigation.

[25]  J. Björkegren,et al.  Plasma Cholesterol–Induced Lesion Networks Activated before Regression of Early, Mature, and Advanced Atherosclerosis , 2014, PLoS genetics.

[26]  B. Hedblad,et al.  Comparison of grey scale median (GSM) measurement in ultrasound images of human carotid plaques using two different softwares , 2013, Clinical physiology and functional imaging.

[27]  M. Trivella,et al.  Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression , 2013, Journal of Translational Medicine.

[28]  F. Pontén,et al.  Profiling of Atherosclerotic Lesions by Gene and Tissue Microarrays Reveals PCSK6 as a Novel Protease in Unstable Carotid Atherosclerosis , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[29]  R. Silverstein,et al.  CD9 Tetraspanin Interacts with CD36 on the Surface of Macrophages: A Possible Regulatory Influence on Uptake of Oxidized Low Density Lipoprotein , 2011, PloS one.

[30]  A. Gabrielsen,et al.  Correlations between clinical variables and gene-expression profiles in carotid plaque instability. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[31]  Chengyu Liang,et al.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX , 2011, Cell Research.

[32]  Tom Wilsgaard,et al.  Carotid Plaque Area and Intima-Media Thickness in Prediction of First-Ever Ischemic Stroke: A 10-Year Follow-Up of 6584 Men and Women: The Tromsø Study , 2011, Stroke.

[33]  D. Teupser,et al.  The Mouse Atherosclerosis Locus at Chromosome 10 (Ath11) Acts Early in Lesion Formation With Subcongenic Strains Delineating 2 Narrowed Regions , 2010, Arteriosclerosis, Thrombosis and Vascular Biology.

[34]  Marios S. Pattichis,et al.  A Review of Noninvasive Ultrasound Image Processing Methods in the Analysis of Carotid Plaque Morphology for the Assessment of Stroke Risk , 2010, IEEE Transactions on Information Technology in Biomedicine.

[35]  R. Virmani,et al.  The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region. , 2010, Atherosclerosis.

[36]  Chun Yuan,et al.  MRI of carotid atherosclerosis: clinical implications and future directions , 2010, Nature Reviews Cardiology.

[37]  Stefan Götz,et al.  SIMAP—a comprehensive database of pre-calculated protein sequence similarities, domains, annotations and clusters , 2009, Nucleic Acids Res..

[38]  M. Post,et al.  Essential role for Bclaf1 in lung development and immune system function , 2009, Cell Death and Differentiation.

[39]  E. Fisher,et al.  Brief Report: Increased Apoptosis in Advanced Atherosclerotic Lesions of Apoe−/− Mice Lacking Macrophage Bcl-2 , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[40]  K. Kaestner,et al.  Conditional Deletion of Krüppel-Like Factor 4 Delays Downregulation of Smooth Muscle Cell Differentiation Markers but Accelerates Neointimal Formation Following Vascular Injury , 2008, Circulation research.

[41]  S Claiborne Johnston,et al.  Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack , 2007, The Lancet.

[42]  Alberto Smith,et al.  Novel Candidate Genes in Unstable Areas of Human Atherosclerotic Plaques , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[43]  P J Gallagher,et al.  Histological Assessment of 526 Symptomatic Carotid Plaques in Relation to the Nature and Timing of Ischemic Symptoms: The Oxford Plaque Study , 2006, Circulation.

[44]  A. Nicolaides,et al.  Carotid Plaque Echolucency Increases the Risk of Stroke in Carotid Stenting: The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) Study , 2004, Circulation.

[45]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[46]  I. Tabas,et al.  Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol , 2004, Cell Death and Differentiation.

[47]  M. Febbraio,et al.  The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? , 2004, The Proceedings of the Nutrition Society.

[48]  E. Fisher,et al.  Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Constantinos S. Pattichis,et al.  Texture-based classification of atherosclerotic carotid plaques , 2003, IEEE Transactions on Medical Imaging.

[50]  I. Gonçalves,et al.  Echolucency of carotid plaques correlates with plaque cellularity. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[51]  C. Liapis,et al.  Carotid Stenosis: Factors Affecting Symptomatology , 2001, Stroke.

[52]  O. Joakimsen,et al.  Echolucent Plaques Are Associated With High Risk of Ischemic Cerebrovascular Events in Carotid Stenosis: The Tromsø Study , 2001, Circulation.

[53]  H. C. Stary,et al.  Natural history and histological classification of atherosclerotic lesions: an update. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[54]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[55]  E. White,et al.  Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins , 1999, Molecular and Cellular Biology.

[56]  A. Newby,et al.  Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.

[57]  M. Bennett.  Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. , 1999, Cardiovascular research.

[58]  A. Katsamouris,et al.  Ultrasonographic and histologic characteristics of symptom-free and symptomatic carotid plaque. , 1996, Cardiovascular surgery.

[59]  S. Korsmeyer,et al.  Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.

[60]  J. Nilsson.  Growth factors and the pathogenesis of atherosclerosis. , 1986, Atherosclerosis.

[61]  Samir Guglani.  Death , 1890, The Lancet.

[62]  T. Varghese,et al.  Histopathologic Validation of Grayscale Carotid Plaque Characteristics Related to Plaque Vulnerability. , 2017, Ultrasound in medicine & biology.